Brief: ADC Therapeutics Receives NYSE Notice Of Non-Compliance With Continued Listing Standards
07/11/2023 12:22
Nov 7 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS RECEIVES NYSE NOTICE OF NON-COMPLIANCE
WITH
CONTINUED LISTING STANDARDS
Source text for Eikon: ID:nGNX7YxPT3
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview